Metformin Pinewood

Metformin, the active ingredient in Metformin Pinewood, is a biguanide presented as an oral tablet for oral use. It is indicated for the management of type 2 diabetes mellitus in adult patients. GNH USA supplies Metformin Pinewood as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformin Pinewood belongs to the biguanide class and is used to treat disorders of glucose metabolism. - Type 2 diabetes mellitus: improves blood glucose control and reduces HbA1c levels.

Metformin Pinewood may cause a range of adverse reactions.

Common Side Effects: - Gastrointestinal upset: nausea, abdominal discomfort, or flatulence. - Diarrhea: loose stools, often transient. - Metallic taste: a transient metallic sensation in the mouth. - Loss of appetite: reduced desire to eat. - Weight loss: modest reduction in body weight. - Vitamin B12 deficiency: decreased absorption over long‑term use.

Serious or Rare Side Effects: - Lactic acidosis: a rare but life‑threatening accumulation of lactate. - Severe hypoglycemia: especially when combined with insulin or sulfonylureas. - Hepatic dysfunction: signs of liver injury. - Skin rash: including severe cutaneous reactions. - Renal impairment: worsening kidney function. - Anaphylactic reaction: rare hypersensitivity.

Metformin Pinewood requires careful patient assessment and monitoring. - Renal function assessment: evaluate eGFR before initiating and periodically thereafter. - Lactic acidosis risk: avoid in patients with severe renal or hepatic impairment. - Alcohol consumption: limit intake to reduce lactic acidosis risk. - Pregnancy and lactation: use only if benefits outweigh potential risks. - Drug interactions: review concomitant medicines that may affect renal clearance or increase hypoglycemia. - Store at ambient temperature: keep below 25°C in the original packaging, protect from moisture.

Metformin Pinewood can interact with several medicines, necessitating vigilance.

Major Interactions (Avoid): - Iodinated contrast agents: may precipitate renal impairment and lactic acidosis. - Cimetidine: can increase metformin plasma concentrations. - Nitrates: concurrent use may cause severe hypotension.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask symptoms of hypoglycemia. - Thiazide diuretics: can attenuate glucose‑lowering effect. - ACE inhibitors or ARBs: monitor renal function and electrolytes.